If chronic inflammation or immune dysregulation is driving the disease, as in autoimmune-related CKD, thymosin alpha-1 (TA-1) works on the immune side
Immunol., 96:104-109 (1994)
, Zenko Sever, A
While this change does not equate to full FDA approval, it reduces a key barrier that has constrained compounding pharmacies
No matching results No matching results No matching results No matching results No matching results No matching results No matching results No matching results No matching results No matching results Your Search Returned No Results
98,99 Then, the hydrophobic C-terminal of AMP may insert into the hydrophobic region of the cell membrane, which may change the conformation of the cell membrane and reduce the activity of P-gp by inhibiting the efflux of chemotherapy drugs, increasing the intracellular drug concentration, and reversing drug resistance of MDR tumor cells